Eli Lilly, Novo Are Weight-Loss Winners. Rivals Won't Be an Issue for Years: Analyst. -- Barrons.com
Alphabet Price Target Maintained With a $205.00/Share by Wedbush
Alphabet Analyst Ratings
New Buy Rating for Broadcom (AVGO), the Technology Giant
Nvidia Price Target Raised to $140.00/Share From $120.00 by Piper Sandler
NVIDIA Analyst Ratings
Bernstein Adjusts Price Target on Amazon.com to $215 From $210, Maintains Outperform Rating
BNP Paribas Exane Adjusts Price Target on Meta Platforms to $382 From $360, Maintains Underperform Rating
BNP Paribas Exane Adjusts Price Target on Alphabet to $210 From $205, Maintains Outperform Rating
BNP Paribas Exane Adjusts Price Target on Microsoft to $525 From $495, Maintains Outperform Rating
Jefferies Reaffirms Their Buy Rating on Amazon (AMZN)
HSBC Raises Price Target on Eli Lilly to $1,100 From $880, Maintains Buy Rating
Wells Fargo Adjusts Price Target on Apple to $275 From $225, Maintains Overweight Rating
Meta Platforms Analyst Ratings
Oppenheimer Adjusts Price Target on Meta Platforms to $525 From $500, Maintains Outperform Rating
New Street Adjusts Price Target on Alphabet to $210 From $200, Maintains Buy Rating
Morgan Stanley Reiterates Overweight on Tesla, Maintains $310 Price Target
Deutsche Bank Adjusts Price Target on Meta Platforms to $525 From $500
Microsoft Analyst Ratings
TD Cowen Adjusts Price Target on Microsoft to $495 From $470, Maintains Buy Rating